New York, NY – Nov. 21, 2019 – The US Pain Collaborative, comprised of advocacy leaders from across the pain...
federal advocacy Articles
Read U.S. Pain’s letter to the FDA
U.S. Pain Foundation was among several hundred organizations and individuals to weigh in on a recent Food and Drug...
How should the FDA evaluate new medications for pain?
We wanted to make you aware of an opportunity to submit public comments to the Food and Drug Administration (FDA)....
Understanding the new CVS opioid policy
Many in the chronic pain community expressed concern after CVS pharmacy announced this month that it will limit opioid...
U.S. Pain goes international
U.S. Pain Foundation's National Director of Policy and Advocacy Cindy Steinberg and California ambassador Katie Golden...
Despite opposition, CMS to replace pain questions on major survey
Despite opposition from groups like the U.S. Pain Foundation, beginning in January 2018, the Center for Medicare and...
Take action to help patients affected by Hurricane Harvey
As Texas and Louisiana continue efforts to keep residents safe, patient-centered organizations are concerned for pain...
U.S. Pain Advocacy Network revitalizes national coalition
In a conference room overlooking Washington, D.C., nonprofit organizations and other stakeholders gathered around the...
Speaking out on the ACA repeal
During the early morning hours of July 28, the U.S. Senate narrowly rejected the most recent proposal to repeal and...
Speaking out on health care reform
On July 25, the Senate voted to start debate on several proposed bills that aim to repeal and replace the Affordable...
Take action on medical cannabis access
U.S. Pain encourages advocates to take action to support the Compassionate Access, Research Expansion, and Respect...
Understanding the BCRA
U.S. Pain remains extremely concerned about the Senate’s proposed Better Care Reconciliation Act (BCRA) and its...